|
|
|
|
LEADER |
05152nam a2200853 4500 |
001 |
ocn746326254 |
003 |
OCoLC |
005 |
20170124072011.4 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
110811s2011 njua ob 001 0 eng d |
010 |
|
|
|z 2010023283
|
040 |
|
|
|a DG1
|b eng
|e pn
|c DG1
|d CDX
|d YDXCP
|d N$T
|d E7B
|d OCLCQ
|d EBLCP
|d OCLCO
|d OCLCQ
|d OCLCF
|d OCLCA
|d OCLCQ
|d IDEBK
|d OCLCQ
|d MHW
|d UKDOC
|d NLGGC
|d OCLCQ
|d COO
|d OCLCQ
|d DEBBG
|d AZK
|d GrThAP
|
019 |
|
|
|a 748534035
|a 756501436
|a 770866893
|a 961512949
|a 962579040
|
020 |
|
|
|a 9780470921371
|q (electronic bk.)
|
020 |
|
|
|a 0470921374
|q (electronic bk.)
|
020 |
|
|
|a 9780470921364
|q (electronic bk.)
|
020 |
|
|
|a 0470921366
|q (electronic bk.)
|
020 |
|
|
|z 9780470386187
|
020 |
|
|
|z 0470386185
|
020 |
|
|
|z 9780470922972
|
020 |
|
|
|z 0470922974
|
029 |
1 |
|
|a AU@
|b 000047980921
|
029 |
1 |
|
|a DKDLA
|b 820120-katalog:000573118
|
029 |
1 |
|
|a NZ1
|b 15915585
|
029 |
1 |
|
|a DEBBG
|b BV043393405
|
035 |
|
|
|a (OCoLC)746326254
|z (OCoLC)748534035
|z (OCoLC)756501436
|z (OCoLC)770866893
|z (OCoLC)961512949
|z (OCoLC)962579040
|
037 |
|
|
|a 10.1002/9780470921371
|b Wiley InterScience
|n http://www3.interscience.wiley.com
|
050 |
|
4 |
|a RS189.5.S65
|b C53 2011
|
060 |
|
4 |
|a 2011 G-724
|
060 |
|
4 |
|a QV 25
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.1
|2 22
|
049 |
|
|
|a MAIN
|
245 |
0 |
0 |
|a Characterization of impurities and degradants using mass spectrometry /
|c edited by Birendra N. Pramanik, Mike S. Lee, Guodong Chen.
|
264 |
|
1 |
|a Hoboken, N.J. :
|b John Wiley,
|c [2011]
|
264 |
|
4 |
|c ©2011
|
300 |
|
|
|a 1 online resource (xxii, 462 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a data file
|2 rda
|
380 |
|
|
|a Bibliography
|
490 |
1 |
|
|a Wiley series on pharmaceutical science and biotechnology
|
505 |
0 |
|
|a Frontmatter -- Methodology. Introduction to Mass Spectrometry / Scott A Smith, Ruth Waddell Smith, Yu Xia, Zheng Ouyang -- LC Method Development and Strategies / Gang Xue, Yining Zhao -- Rapid Analysis of Drug-Related Substances Using Desorption Electrospray Ionization and Direct Analysis in Real Time Ionization Mass Spectrometry / Hao Chen, Jiwen Li -- Orbitrap High-Resolution Applications / Robert J Strife -- Structural Characterization of Impurities and Degradation Products in Pharmaceuticals Using High-Resolution LC-MS and Online Hydrogen/Deuterium Exchange Mass Spectrometry / Guodong Chen, Birendra N Pramanik -- Isotope Patten Recognition on Molecular Formula Determination for Structural Identification of Impurities / Ming Gu -- Application. Practical Application of Very High-Pressure Liquid Chromatography across the Pharmaceutical Development₆Manufacturing Continuum / Brent Kleintop, Qinggang Wang -- Impurity Identification for Drug Substances / David W Berberich, Tao Jiang, Joseph McClurg, Frank Moser, R Randy Wilhelm -- Impurity Identification in Process Chemistry by Mass Spectrometry / David Q Liu, Mingjiang Sun, Lianming Wu -- Structure Elucidation of Pharmaceutical Impurities and Degradants in Drug Formulation Development / Changkang Pan, Frances Liu, Michael Motto -- Investigation of Degradation Products and Extractables in Developing Topical OTC (Over the Counter) and NCE (New Chemical Entity) Consumer Healthcare Medication Products / Fa Zhang -- Characterization of Impurities and Degradants in Protein Therapeutics by Mass Spectrometry / Li Tao, Michael Ackerman, Wei Wu, Peiran Liu, Reb Russell -- Identification and Quantification of Degradants and Impurities in Antibodies / David M Hambly, Himanshu S Gadgil -- Index.
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
650 |
|
0 |
|a Drugs
|x Analysis.
|
650 |
|
0 |
|a Drugs
|x Spectra.
|
650 |
|
0 |
|a Mass spectrometry.
|
650 |
|
0 |
|a Contamination (Technology)
|
650 |
|
2 |
|a Mass Spectrometry
|x methods.
|
650 |
|
2 |
|a Pharmaceutical Preparations
|x analysis.
|
650 |
|
2 |
|a Drug Contamination.
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a Contamination (Technology)
|2 fast
|0 (OCoLC)fst00876602
|
650 |
|
7 |
|a Drugs
|x Analysis.
|2 fast
|0 (OCoLC)fst00898769
|
650 |
|
7 |
|a Drugs
|x Spectra.
|2 fast
|0 (OCoLC)fst00898921
|
650 |
|
7 |
|a Mass spectrometry.
|2 fast
|0 (OCoLC)fst01011435
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Pramanik, Birendra N.,
|d 1944-
|
700 |
1 |
|
|a Lee, Mike S.,
|d 1960-
|
700 |
1 |
|
|a Chen, Guodong.
|
710 |
2 |
|
|a Wiley InterScience (Online service)
|
776 |
0 |
8 |
|i Print version:
|t Characterization of impurities and degradants using mass spectrometry.
|d Hoboken, N.J. : John Wiley, ©2011
|z 9780470386187
|w (DLC) 2010023283
|w (OCoLC)430842666
|
830 |
|
0 |
|a Wiley series on pharmaceutical science and biotechnology.
|
856 |
4 |
0 |
|u https://doi.org/10.1002/9780470921371
|z Full Text via HEAL-Link
|
994 |
|
|
|a 92
|b DG1
|